vs
Encompass Health Corp（EHC）とFabrinet（FN）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.1B、Fabrinetの約1.4倍）。Fabrinetの純利益率が高く（9.9% vs 9.5%、差は0.5%）。Fabrinetの前年同期比売上増加率が高い（35.9% vs 9.9%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-5.3M）。過去8四半期でFabrinetの売上複合成長率が高い（24.4% vs 8.3%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
Fabrinet（証券コード：FN）はS&Pミッドキャップ400指数の構成銘柄です。同指数はS&Pダウジョーンズインデックスが管理し、主に米国の中型企業400社で構成され、構成企業が複数の株式クラスを発行している場合は構成数が400を超えることもあります。
EHC vs FN — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $1.1B |
| 純利益 | $146.1M | $112.6M |
| 粗利率 | — | 12.2% |
| 営業利益率 | 16.7% | 10.1% |
| 純利益率 | 9.5% | 9.9% |
| 売上前年比 | 9.9% | 35.9% |
| 純利益前年比 | 20.8% | 30.0% |
| EPS（希薄化後） | $1.43 | $3.11 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.5B | $978.1M | ||
| Q2 25 | $1.5B | $909.7M | ||
| Q1 25 | $1.5B | $871.8M | ||
| Q4 24 | $1.4B | $833.6M | ||
| Q3 24 | $1.4B | $804.2M | ||
| Q2 24 | $1.3B | $753.3M | ||
| Q1 24 | $1.3B | $731.5M |
| Q4 25 | $146.1M | $112.6M | ||
| Q3 25 | $126.5M | $95.9M | ||
| Q2 25 | $142.1M | $87.2M | ||
| Q1 25 | $151.5M | $81.3M | ||
| Q4 24 | $120.9M | $86.6M | ||
| Q3 24 | $108.2M | $77.4M | ||
| Q2 24 | $114.1M | $81.1M | ||
| Q1 24 | $112.5M | $80.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | 16.7% | 10.1% | ||
| Q3 25 | 14.9% | 9.6% | ||
| Q2 25 | 16.2% | 9.8% | ||
| Q1 25 | 16.4% | 9.0% | ||
| Q4 24 | 14.3% | 9.5% | ||
| Q3 24 | 13.6% | 9.6% | ||
| Q2 24 | 14.3% | 9.7% | ||
| Q1 24 | 13.6% | 9.7% |
| Q4 25 | 9.5% | 9.9% | ||
| Q3 25 | 8.6% | 9.8% | ||
| Q2 25 | 9.7% | 9.6% | ||
| Q1 25 | 10.4% | 9.3% | ||
| Q4 24 | 8.6% | 10.4% | ||
| Q3 24 | 8.0% | 9.6% | ||
| Q2 24 | 8.8% | 10.8% | ||
| Q1 24 | 8.5% | 11.1% |
| Q4 25 | $1.43 | $3.11 | ||
| Q3 25 | $1.24 | $2.66 | ||
| Q2 25 | $1.39 | $2.41 | ||
| Q1 25 | $1.48 | $2.25 | ||
| Q4 24 | $1.18 | $2.38 | ||
| Q3 24 | $1.06 | $2.13 | ||
| Q2 24 | $1.12 | $2.22 | ||
| Q1 24 | $1.10 | $2.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $960.8M |
| 総負債低いほど良い | $2.4B | — |
| 株主資本純資産 | $2.4B | $2.2B |
| 総資産 | $7.1B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $960.8M | ||
| Q3 25 | $48.7M | $968.8M | ||
| Q2 25 | $99.1M | $934.2M | ||
| Q1 25 | $95.8M | $950.7M | ||
| Q4 24 | $85.4M | $934.6M | ||
| Q3 24 | $147.8M | $908.9M | ||
| Q2 24 | $154.4M | $858.6M | ||
| Q1 24 | $134.4M | $794.0M |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $2.4B | $2.2B | ||
| Q3 25 | $2.4B | $2.1B | ||
| Q2 25 | $2.3B | $2.0B | ||
| Q1 25 | $2.2B | $1.9B | ||
| Q4 24 | $2.1B | $1.8B | ||
| Q3 24 | $2.0B | $1.8B | ||
| Q2 24 | $1.8B | $1.7B | ||
| Q1 24 | $1.7B | $1.7B |
| Q4 25 | $7.1B | $3.3B | ||
| Q3 25 | $6.9B | $3.0B | ||
| Q2 25 | $6.8B | $2.8B | ||
| Q1 25 | $6.6B | $2.6B | ||
| Q4 24 | $6.5B | $2.5B | ||
| Q3 24 | $6.5B | $2.4B | ||
| Q2 24 | $6.4B | $2.3B | ||
| Q1 24 | $6.2B | $2.2B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $46.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $-5.3M |
| FCFマージンFCF / 売上 | 7.6% | -0.5% |
| 設備投資強度設備投資 / 売上 | 14.8% | 4.6% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 0.41× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $102.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $46.3M | ||
| Q3 25 | $270.8M | $102.6M | ||
| Q2 25 | $270.2M | $55.1M | ||
| Q1 25 | $288.6M | $74.2M | ||
| Q4 24 | $278.8M | $115.9M | ||
| Q3 24 | $267.8M | $83.2M | ||
| Q2 24 | $217.4M | $83.1M | ||
| Q1 24 | $238.8M | $100.9M |
| Q4 25 | $116.7M | $-5.3M | ||
| Q3 25 | $83.7M | $57.3M | ||
| Q2 25 | $113.3M | $4.7M | ||
| Q1 25 | $125.5M | $45.7M | ||
| Q4 24 | $80.1M | $94.0M | ||
| Q3 24 | $120.3M | $62.9M | ||
| Q2 24 | $60.5M | $70.4M | ||
| Q1 24 | $99.4M | $87.3M |
| Q4 25 | 7.6% | -0.5% | ||
| Q3 25 | 5.7% | 5.9% | ||
| Q2 25 | 7.8% | 0.5% | ||
| Q1 25 | 8.6% | 5.2% | ||
| Q4 24 | 5.7% | 11.3% | ||
| Q3 24 | 8.9% | 7.8% | ||
| Q2 24 | 4.6% | 9.3% | ||
| Q1 24 | 7.6% | 11.9% |
| Q4 25 | 14.8% | 4.6% | ||
| Q3 25 | 12.7% | 4.6% | ||
| Q2 25 | 10.8% | 5.5% | ||
| Q1 25 | 11.2% | 3.3% | ||
| Q4 24 | 14.1% | 2.6% | ||
| Q3 24 | 10.9% | 2.5% | ||
| Q2 24 | 12.1% | 1.7% | ||
| Q1 24 | 10.6% | 1.9% |
| Q4 25 | 2.37× | 0.41× | ||
| Q3 25 | 2.14× | 1.07× | ||
| Q2 25 | 1.90× | 0.63× | ||
| Q1 25 | 1.90× | 0.91× | ||
| Q4 24 | 2.31× | 1.34× | ||
| Q3 24 | 2.48× | 1.07× | ||
| Q2 24 | 1.91× | 1.02× | ||
| Q1 24 | 2.12× | 1.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
